N-acetyl-l-cysteine fosters inactivation and transfer to endolysosomes of c-Src

Free Radical Biology and Medicine

Volumn 45, Issue 11, 2008, Pages 1566-1572

  Krasnowska, Ewa K ^a   Pittaluga, Eugenia ^a   Brunati, Anna Maria ^b   Brunelli, Roberto ^c   Costa, Graziella ^a   De Spirito, Marco ^d   Serafino, Annalucia ^a   Ursini, Fulvio ^b   Parasassi, Tiziana ^a  

^a CNR   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

^d CATHOLIC UNIVERSITY   (Italy)

Author keywords

Acidic endolysosomes; c Src inactivation; Free radicals; N acetyl l cysteine; Tyrosine phosphorylation

Indexed keywords

ACETYLCYSTEINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL; CELL MEMBRANE; COLON CARCINOMA; CONTROLLED STUDY; DRUG MECHANISM; EXPERIMENTAL MOUSE; KINETICS; MOUSE; NONHUMAN; ONCOGENE SRC; OXIDATION; PHOSPHORYLATION; PRIORITY JOURNAL;

ACETYLCYSTEINE; AMINO ACID SEQUENCE; ANIMALS; BLOTTING, WESTERN; CACO-2 CELLS; CELL LINE, TUMOR; CELL MEMBRANE; FLUORESCENT ANTIBODY TECHNIQUE; FREE RADICAL SCAVENGERS; HUMANS; IMMUNOPRECIPITATION; KINETICS; LYSOSOMES; MICROSCOPY, CONFOCAL; OXIDATION-REDUCTION; PHOSPHORYLATION; PROTEIN-TYROSINE KINASES; RATS;

EID: 56049088720     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2008.09.012     Document Type: Article

References (33)

1. Frame M.C. Src in cancer: deregulation and consequences for cell behavior. Biochim. Biophys. Acta 1602 (2002) 114-130
2. Hunter T., and Sefton B.M. Transforming gene product of Rous sarcoma virus phosphorylates tyrosine. Proc. Natl. Acad. Sci. USA 77 (1980) 1311-1315
3. Irby R.B., Mao W., Coppola D., Kang J., Loubeau J.M., Trudeau W., Karl R., Fujita D.J., Jove R., and Yeatman T.J. Activating SRC mutation in a subset of advanced human colon cancers. Nat. Genet. 21 (1999) 187-190
4. Irby R.B., and Yeatman T.J. Role of Src expression and activation in human cancer. Oncogene 19 (2000) 5636-5642
5. Ishizawar R., and Parsons S.J. c-Src and cooperating partners in human cancer. Cancer Cell 6 (2004) 209-214
6. Martin J.S. The hunting of the Src. Nat. Rev. Mol. Cell. Biol. 2 (2001) 467-475
7. Yeatman T.J. A renaissance for SRC. Nat. Rev. Cancer 4 (2004) 470-480
8. Biscardi J.S., Ishizawar R.C., Silva C.M., and Parsons S.J. Tyrosine kinase signalling in breast cancer: epidermal growth factor receptor and c-Src interactions in breast cancer. Breast Cancer Res. 2 (2000) 203-210
9. Alvarez R.H., Kantarjian H.M., and Cortes J.E. The role of Src in solid and hematologic malignancies: development of new-generation Src inhibitors. Cancer 107 (2006) 1918-1929
10. Puttini M., Coluccia A.M., Boschelli F., Cleris L., Marchesi E., Donella-Deana A., Ahmed S., Redaelli S., Piazza R., Magistroni V., Andreoni F., Scapozza L., Formelli F., and Gambacorti-Passerini C. In vitro and in vivo activity of SKI-606, a novel Src-Abl inhibitor, against imatinib-resistant Bcr-Abl+ neoplastic cells. Cancer Res. 66 (2006) 11314-11322
11. Sandilands E., Cans C., Fincham V.J., Brunton V.G., Mellor H., Prendergast G.C., Norman J.C., Superti-Furga G., and Frame M.C. RhoB and actin polymerization coordinate Src activation with endosome-mediated delivery to the membrane. Dev. Cell 7 (2004) 855-869
12. Akhand A.A., Pu M., Senga T., Kato M., Suzuki H., Miyata T., Hamaguchi M., and Nakashima I. Nitric oxide controls src kinase activity through a sulfhydryl group modification-mediated Tyr-527-independent and Tyr-416-linked mechanism. J. Biol. Chem. 274 (1999) 25821-25826
13. Minetti M., Mallozzi C., and Di Stasi A.M. Peroxynitrite activates kinases of the src family and upregulates tyrosine phosphorylation signaling. Free Radic. Biol. Med. 33 (2002) 744-754
14. Pu M., Akhand A.A., Kato M., Hamaguchi M., Koike T., Iwata H., Sabe H., Suzuki H., and Nakashima I. Evidence of a novel redox-linked activation mechanism for the Src kinase which is independent of tyrosine 527-mediated regulation. Oncogene 13 (1996) 2615-2622
15. Serafini M., Mallozzi C., Di Stasi A.M., and Minetti M. Peroxynitrite-dependent upregulation of SRC kinases in red blood cells: strategies to study the activation mechanisms. Methods Enzymol. 396 (2005) 215-229
16. 2+ levels. J. Biol. Chem. 275 (2000) 12223-12230
17. Avizienyte E., and Frame M.C. Src and FAK signaling controls adhesion fate and the epithelial-to-mesenchymal transition. Curr. Opin. Cell Biol. 17 (2005) 547
18. Parasassi T., Brunelli R., Bracci-Laudiero L., Greco G., Gustafsson A.C., Krasnowska E.K., Lundeberg J., Lundeberg T., Pittaluga E., Romano M.C., and Serafino A. Differentiation of normal and cancer cells induced by sulfhydryl reduction: biochemical and molecular mechanisms. Cell Death Differ. 12 (2005) 1285-1296
19. Chiarugi P. PTPs versus PTKs: the redox side of the coin. Free Radic. Res. 39 (2005) 353-364
20. Cooper C.E., Patel R.P., Brookes P.S., and Darley-Usmar V.M. Nanotransducers in cellular redox signaling: modification of thiols by reactive oxygen and nitrogen species. Trends Biochem. Sci. 27 (2002) 489-492
21. Giles G.I. The redox regulation of thiol dependent signaling pathways in cancer. Curr. Pharm. Des. 12 (2006) 4427-4443
22. Garant M.J., Kole S., Maksimova E.M., and Bernier M. Reversible change in thiol redox status of the insulin receptor α-subunit in intact cells. Biochemistry 38 (1999) 5896-5904
23. Laragione T., Bonetto V., Casoni F., Massignan T., Bianchi G., Gianazza E., and Ghezzi P. Redox regulation of surface protein thiols: identification of integrin α-4 as a molecular target by using redox proteomics. Proc. Natl. Acad. Sci. USA 100 (2003) 14737-14741
24. Ullian M.E., Gelasco A.K., Fitzgibbon W.R., Beck C.N., and Morinelli T.A. N-acetylcysteine decreases angiotensin II receptor binding in vascular smooth muscle cells. J. Am. Soc. Nephrol. 16 (2005) 2346-2353
25. Donella-Deana A., James P., Staudenmann W., Cesaro L., Marin O., Brunati A.M., Ruzzene M., and Pinna L.A. Isolation from spleen of a 57-kDa protein substrate of the tyrosine kinase Lyn: identification as a protein related to protein disulfide-isomerase and localisation of the phosphorylation sites. Eur. J. Biochem. 235 (1996) 18-25
26. Chantret I., Rodolosse A., Barbat A., Dussaulx E., Brot-Laroche E., Zweibaum A., and Rousset M. Differential expression of sucrase-isomaltase in clones isolated from early and late passages of the cell line Caco-2: evidence for glucose-dependent negative regulation. J. Cell Sci. 107 (1994) 213-225
27. Fantini J., Abadie B., Tirard A., Remy L., Ripert J.P., el Battari A., and Marvaldi J. Spontaneous and induced dome formation by two clonal cell populations derived from a human adenocarcinoma cell line, HT29. J. Cell Sci. 83 (1986) 235-249
28. Dehm S., Senger M.A., and Bonham K. SRC transcriptional activation in a subset of human colon cancer cell lines. FEBS Lett. 487 (2001) 367-371
29. Rhee S.G. H2O2, a necessary evil for cell signaling. Science 312 (2006) 1882-1883
30. Giannoni E., Buricchi F., Raugei G., Ramponi G., and Chiarugi P. Intracellular reactive oxygen species activate Src tyrosine kinase during cell adhesion and anchorage-dependent cell growth. Mol. Cell. Biol. 25 (2005) 6391-6403
31. Nakashima I., Takeda K., Kawamoto Y., Okuno Y., Kato M., and Suzuki H. Redox control of catalytic activities of membrane-associated protein tyrosine kinases. Arch. Biochem. Biophys. 434 (2005) 3-10
32. Oo M.L., Senga T., Thant A.A., Amin A.R., Huang P., Mon N.N., and Hamaguchi M. Cysteine residues in the C-terminal lobe of Src: their role in the suppression of the Src kinase. Oncogene 22 (2003) 1411-1417
33. Danon A. Redox reactions of regulatory proteins: do kinetics promote specificity?. Trends Biochem. Sci. 27 (2002) 197-203